Safety evaluation of excessive intake of polyphenol.

Safety evaluation of excessive intake of polyphenol. - Safety evaluation of polyphenol.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039789

Enrollment

Registered

2020-03-12

Start date

2020-03-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake of polyphenol for 4 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Men and women between the ages of 20 and under 75 who wish to voluntarily participate in clinical trials and obtain written consent. (2) Healthy subjects who have not taken any treatment or medication for the disease. (3) Subjects who can maintain their daily habits during the test period.

Exclusion criteria

Exclusion criteria: (1) Subjects with serious illness (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or mental illness. (2)Subjects with a history of serious illness. (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) (3)Subjects who have large changes in diet and exercise and cannot maintain their daily lifestyle.

Design outcomes

Primary

Measure	Time frame
(1) The incidence of side effects and/or adverse events. (2) The results of clinical examination.	—

Countries

Japan

Contacts

Public ContactTatsuo Uetake

CXwellness, Inc. CEO

uetake@cx-wellness.com03-6225-5601

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026